Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrowth improved, but quality of life did not.

CTP-543 is generally safe for treating alopecia areata.

AC5 improves hair loss and hair quality with high satisfaction rates.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Baricitinib is a safe and effective treatment for severe alopecia areata.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The albumin change rate helps predict treatment success in AIDS-related non-Hodgkin lymphoma.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Baricitinib was effective in treating both early and late onset alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

The study helps doctors use patient images to understand and apply SALT scores for treating severe alopecia areata.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.